磁振造影导引神经外科消融市场规模、份额和成长分析（按产品、适应症、最终用途和地区划分）：产业预测（2026-2033 年）

预计 2024 年 MRI 导引神经外科消融市场规模将达到 6.3543 亿美元，从 2025 年的 6.8436 亿美元增长到 2033 年的 12.3882 亿美元，在预测期（2026-2033 年）内复合年增长率为 7.7%。

受神经系统疾病和脑肿瘤发生率上升以及微创手术技术发展趋势的推动，磁振造影引导神经外科消融术市场正经历强劲成长。患者青睐此类手术，因为外科医生可以使用专用器械最大限度地减少组织损伤，从而缩短恢復时间并降低手术风险。即时高解析度磁振造影技术的创新显着提高了手术的准确性和安全性，增强了术中可视化和适应性。此外，四束追踪等技术的进步也提高了治疗药物难治性震颤等疾病的能力。这一市场成长反映出，越来越多的医疗专业人士认识到微创技术在神经外科领域相较于传统方法所具有的诸多优势。

磁振造影导引神经外科消融术市场驱动因素

神经系统疾病的日益普遍是推动磁振造影引导神经外科消融术需求成长的主要因素。多种影响神经系统的疾病可导致危及生命的状况和严重的残疾。随着人们对这些疾病的认识不断提高，对有效治疗方法的需求也日益增长。在此背景下，磁振造影导引神经外科消融术等创新方法因其在标靶脑内病灶的有效性和精准性而备受关注。对先进治疗技术的日益重视反映了医疗保健领域的一个更广泛趋势，即采用最尖端科技来改善患者预后并应对神经系统疾病的复杂性。

磁振造影引导神经外科消融术市场限制因素

磁振造影导引神经外科消融术市场面临许多限制因素，主要源自于保险覆盖范围和报销方面的挑战。儘管这些创新手术为神经系统疾病患者提供了宝贵的治疗选择，但保险覆盖范围和报销政策的差异可能会给寻求治疗的患者带来巨大的经济障碍。在许多情况下，保险公司无法全额报销磁振造影导引神经外科消融术的费用，导致患者需要承担高额的自付费用，这可能会成为选择治疗方案的障碍。此外，不同地区和保险计划之间缺乏标准化的报销流程，进一步加剧了财务困境，导致患者获得治疗的机会不均等，并可能阻碍这项先进技术的广泛应用。解决这些挑战对于改善磁振造影引导神经外科消融术的可及性以及促进其融入传统医疗保健体系至关重要。

磁振造影导引神经外科消融术市场趋势

磁振造影导引神经外科消融市场正日益受到以病人为中心的医疗模式的影响。这种模式优先考虑根据每位患者的独特需求和意愿量身定制的个人化治疗方法。该模式透过专注于个人化的治疗计划来提升医疗质量，这些计划充分考虑了患者的具体病情和特征，从而实现微创且精准的手术。透过营造协作和共同决策的氛围，患者能够积极参与自身的医疗保健过程。这种对个人化的重视不仅改善了患者的体验和满意度，也与神经外科向更具适应性和回应性的医疗服务模式的全面转变相契合，最终带来更好的临床疗效。

目录

介绍

• 分析目的
• 分析范围
• 定义

分析方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场进行机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考量因素

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场魅力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管环境
• 案例研究

全球磁振造影导引神经外科消融市场规模及产品复合年增长率（2026-2033 年）

• 磁振造影导引雷射消熔系统
• 磁共振导引射频消融术系统
• 磁共振引导聚焦超音波系统
• 配件

全球磁振造影导引神经外科消融市场规模及依适应症分類的复合年增长率（2026-2033 年）

• 瘤
• 癫痫
• 疼痛管理
• 血管畸形

全球磁振造影导引神经外科消融市场规模及依最终用途分類的复合年增长率（2026-2033 年）

• 医院
• 诊所
• 门诊手术中心

全球磁振造影导引神经外科消融市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争格局

• 前五大公司对比
• 主要企业市场定位（2025 年）
• 主要企业采取的策略
• 近期市场趋势
• 主要企业市占率（2025 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 年比营收比较（2023-2025）

主要企业简介

• Monteris Medical（美国）
• InSightec有限公司（以色列）
• 加拿大普罗芬德医疗公司
• Medtronic plc（Ireland）
• 波士顿科学公司（美国）
• AngioDynamics公司（美国）
• ClearPoint Neuro公司（美国）
• Elekta AB（Sweden）
• Accuray 公司（美国）
• Brainlab AG（德国）
• 瓦里安医疗系统（美国）
• 雅培实验室（美国）
• 西门子医疗股份公司（德国）
• 飞利浦医疗保健（荷兰）
• GE医疗（美国）

结论与建议

MRI-Guided Neurosurgical Ablation Market size was valued at USD 635.43 Million in 2024 and is poised to grow from USD 684.36 Million in 2025 to USD 1238.82 Million by 2033, growing at a CAGR of 7.7% during the forecast period (2026-2033).

The MRI-guided neurosurgical ablation market is experiencing robust growth driven by the rising prevalence of nervous system disorders and brain tumors, alongside a shift towards minimally invasive surgical techniques. These approaches are favored by patients due to their potential for quicker recovery and reduced surgical risks, as surgeons utilize specialized instruments to minimize tissue damage. Innovations in real-time, high-resolution MRI have significantly enhanced the precision and safety of these procedures, enabling better visualization and adaptation during surgery. Additionally, advancements such as four-tract tractography are improving treatment capabilities for conditions like medication-resistant tremors. This market growth reflects a growing endorsement from medical professionals who recognize the myriad benefits of minimally invasive techniques over traditional methods in neurosurgery.

Top-down and bottom-up approaches were used to estimate and validate the size of the MRI-Guided Neurosurgical Ablation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

MRI-Guided Neurosurgical Ablation Market Segments Analysis

Global MRI-Guided Neurosurgical Ablation Market is segmented by Product, Indication, End-Use and region. Based on Product, the market is segmented into MRI Guided Laser Ablation Systems, MRI Guided RF Ablation Systems, MRI Guided Focused Ultrasound Systems and Accessories. Based on Indication, the market is segmented into Tumors, Epilepsy, Pain Management and Vascular Malformations. Based on End-Use, the market is segmented into Hospitals, Clinics and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the MRI-Guided Neurosurgical Ablation Market

The growing prevalence of neurological disorders significantly drives the demand for MRI-guided neurosurgical ablation. Various diseases affect the nervous system, leading to conditions that can be life-threatening or result in severe disabilities. As awareness of these disorders rises, so does the need for effective treatment options. Among these, innovative approaches such as MRI-guided neurosurgical ablation are gaining traction, owing to their efficacy and precision in targeting affected areas within the brain. This increased focus on advanced therapeutic techniques reflects a broader trend in healthcare, where cutting-edge technologies are being embraced to enhance patient outcomes and address the complexities of neurological health.

Restraints in the MRI-Guided Neurosurgical Ablation Market

The MRI-guided neurosurgical ablation market faces significant constraints primarily due to insurance and reimbursement challenges. Although these innovative procedures offer valuable treatment options for individuals with neurological disorders, the variability in insurance coverage and reimbursement policies can create substantial financial obstacles for patients seeking these interventions. In many cases, insurance providers may offer incomplete coverage for the costs associated with MRI-guided neurosurgical ablation, resulting in considerable out-of-pocket expenses for patients, which may deter them from pursuing such treatments. Moreover, the absence of standardized reimbursement practices across different regions and insurance plans complicates the financial landscape, leading to disparities in patient access and potentially hindering the widespread adoption of this advanced technology. Tackling these issues is essential for improving access to MRI-guided neurosurgical ablation and facilitating its integration into conventional healthcare systems.

Market Trends of the MRI-Guided Neurosurgical Ablation Market

The MRI-guided neurosurgical ablation market is increasingly influenced by the trend of patient-centric care, which prioritizes individualized treatment approaches tailored to each patient's unique needs and preferences. This model enhances the quality of care by focusing on personalized treatment plans that consider the specific medical conditions and characteristics of patients, allowing for minimally invasive and precisely targeted procedures. By fostering a culture of collaboration and shared decision-making, patients become active participants in their healthcare journeys. This emphasis on personalization not only improves patient experiences and satisfaction but also aligns with the overarching shift towards more adaptive and responsive healthcare services within the neurosurgical field, ultimately driving positive clinical outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global MRI-Guided Neurosurgical Ablation Market Size by Product & CAGR (2026-2033)

• Market Overview
• MRI Guided Laser Ablation Systems
• MRI Guided RF Ablation Systems
• MRI Guided Focused Ultrasound Systems
• Accessories

Global MRI-Guided Neurosurgical Ablation Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Tumors
• Epilepsy
• Pain Management
• Vascular Malformations

Global MRI-Guided Neurosurgical Ablation Market Size by End-Use & CAGR (2026-2033)

• Market Overview
• Hospitals
• Clinics
• Ambulatory Surgical Centers

Global MRI-Guided Neurosurgical Ablation Market Size & CAGR (2026-2033)

• North America (Product, Indication, End-Use)
  • US
  • Canada
• Europe (Product, Indication, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Indication, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Indication, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Indication, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Monteris Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InSightec Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Profound Medical Corp. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ClearPoint Neuro, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elekta AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accuray Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brainlab AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Varian Medical Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations